Astrana Health (ASTH) Receivables - Net (2011 - 2026)

Astrana Health (ASTH) has 16 years of Receivables - Net data on file, last reported at $467.4 million in Q1 2026.

• Quarterly Receivables - Net rose 93.88% year-over-year to $467.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $467.4 million (up 93.88% YoY) and the FY2025 annual result came in at $374.5 million, up 35.68% from the prior year.
• Receivables - Net rose to $467.4 million in Q1 2026 per ASTH's latest filing, from $374.5 million in the prior quarter.
• The five-year high for Receivables - Net was $467.4 million in Q1 2026, with the low at $1.0 million in Q1 2022.
• Average Receivables - Net over 5 years is $152.6 million, with a median of $66.9 million recorded in 2023.
• Year-over-year, Receivables - Net slumped 93.88% in 2022 and soared 7447.67% in 2023.
• Astrana Health's Receivables - Net stood at $62.4 million in 2022, then retreated by 5.95% to $58.7 million in 2023, then surged by 370.11% to $276.0 million in 2024, then surged by 35.68% to $374.5 million in 2025, then grew by 24.82% to $467.4 million in 2026.
• Business Quant data shows ASTH's Receivables - Net at $467.4 million in Q1 2026, $374.5 million in Q4 2025, and $381.2 million in Q3 2025.